Valid-NEO: A Multi-Omics Platform for Neoantigen Detection and Quantification from Limited Clinical Samples
Simple Summary
- Supplementary File 1:
ZIP-Document (ZIP, 11053 KiB)
Terai, Y.L.; Huang, C.; Wang, B.; Kang, X.; Han, J.; Douglass, J.; Hsiue, E.H.-C.; Zhang, M.; Purohit, R.; deSilva, T.; Wang, Q. Valid-NEO: A Multi-Omics Platform for Neoantigen Detection and Quantification from Limited Clinical Samples. Cancers 2022, 14, 1243. https://doi.org/10.3390/cancers14051243
Terai YL, Huang C, Wang B, Kang X, Han J, Douglass J, Hsiue EH-C, Zhang M, Purohit R, deSilva T, Wang Q. Valid-NEO: A Multi-Omics Platform for Neoantigen Detection and Quantification from Limited Clinical Samples. Cancers. 2022; 14(5):1243. https://doi.org/10.3390/cancers14051243
Chicago/Turabian StyleTerai, Yuri L., Chun Huang, Baoli Wang, Xiaonan Kang, Jing Han, Jacqueline Douglass, Emily H.-C. Hsiue, Ming Zhang, Raj Purohit, Taylor deSilva, and Qing Wang. 2022. "Valid-NEO: A Multi-Omics Platform for Neoantigen Detection and Quantification from Limited Clinical Samples" Cancers 14, no. 5: 1243. https://doi.org/10.3390/cancers14051243